165 related articles for article (PubMed ID: 25638212)
1. Autologous dermal fibroblast injections slow atrioventricular conduction and ventricular rate in atrial fibrillation in swine.
Tondato F; Zeng H; Goodchild T; Ng FS; Chronos N; Peters NS
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):439-46. PubMed ID: 25638212
[TBL] [Abstract][Full Text] [Related]
2. Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart.
Bunch TJ; Mahapatra S; Bruce GK; Johnson SB; Miller DV; Horne BD; Wang XL; Lee HC; Caplice NM; Packer DL
Circulation; 2006 May; 113(21):2485-94. PubMed ID: 16717152
[TBL] [Abstract][Full Text] [Related]
3. Characterization of atrioventricular nodal behavior and ventricular response during atrial fibrillation before and after a selective slow-pathway ablation.
Blanck Z; Dhala AA; Sra J; Deshpande SS; Anderson AJ; Akhtar M; Jazayeri MR
Circulation; 1995 Feb; 91(4):1086-94. PubMed ID: 7850945
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of ventricular rate control after radiofrequency modification of atrioventricular conduction in patients with atrial fibrillation.
Markowitz SM; Stein KM; Lerman BB
Circulation; 1996 Dec; 94(11):2856-64. PubMed ID: 8941113
[TBL] [Abstract][Full Text] [Related]
5. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327
[TBL] [Abstract][Full Text] [Related]
6. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
[TBL] [Abstract][Full Text] [Related]
7. Nodal recovery, dual pathway physiology, and concealed conduction determine complex AV dynamics in human atrial tachyarrhythmias.
Masè M; Glass L; Disertori M; Ravelli F
Am J Physiol Heart Circ Physiol; 2012 Nov; 303(10):H1219-28. PubMed ID: 23001833
[TBL] [Abstract][Full Text] [Related]
8. Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter.
Della Bella P; Carbucicchio C; Tondo C; Riva S
J Am Coll Cardiol; 1995 Jan; 25(1):39-46. PubMed ID: 7798523
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
[TBL] [Abstract][Full Text] [Related]
10. Dual AV nodal pathways and conduction during atrial fibrillation.
Hegbom F; Orning OM; Gjesdal K
Scand Cardiovasc J; 2003 Sep; 37(4):199-204. PubMed ID: 12944207
[TBL] [Abstract][Full Text] [Related]
11. Electrical Remodeling of the Atrioventricular Node Caused by Persistent Atrial Fibrillation in Humans.
Sairaku A; Nakano Y; Suenari K; Tokuyama T; Kawazoe H; Matsumura H; Tomomori S; Amioka M; Kihara Y
J Cardiovasc Electrophysiol; 2016 Aug; 27(8):918-22. PubMed ID: 27098002
[TBL] [Abstract][Full Text] [Related]
12. Achieving regular slow rhythm during atrial fibrillation without atrioventricular nodal ablation: selective vagal stimulation plus ventricular pacing.
Zhang Y; Mazgalev TN
Heart Rhythm; 2004 Oct; 1(4):469-75. PubMed ID: 15851201
[TBL] [Abstract][Full Text] [Related]
13. Determinants of the ventricular rate during atrial fibrillation.
Toivonen L; Kadish A; Kou W; Morady F
J Am Coll Cardiol; 1990 Nov; 16(5):1194-200. PubMed ID: 2229766
[TBL] [Abstract][Full Text] [Related]
14. AV nodal function during atrial fibrillation: the role of electrotonic modulation of propagation.
Meijler FL; Jalife J; Beaumont J; Vaidya D
J Cardiovasc Electrophysiol; 1996 Sep; 7(9):843-61. PubMed ID: 8884513
[TBL] [Abstract][Full Text] [Related]
15. High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia.
McGuire MA; Bourke JP; Robotin MC; Johnson DC; Meldrum-Hanna W; Nunn GR; Uther JB; Ross DL
Circulation; 1993 Nov; 88(5 Pt 1):2315-28. PubMed ID: 8222125
[TBL] [Abstract][Full Text] [Related]
16. Bimodal RR interval distribution in chronic atrial fibrillation: impact of dual atrioventricular nodal physiology on long-term rate control after catheter ablation of the posterior atrionodal input.
Tebbenjohanns J; Schumacher B; Korte T; Niehaus M; Pfeiffer D
J Cardiovasc Electrophysiol; 2000 May; 11(5):497-503. PubMed ID: 10826927
[TBL] [Abstract][Full Text] [Related]
17. Endoscopy-assisted radiofrequency ablation around the coronary sinus ostium in dogs: its effects on atrioventricular nodal properties and ventricular response during atrial fibrillation.
Tanaka K; Cha YM; Fujimura O
J Cardiovasc Electrophysiol; 1996 Nov; 7(11):1063-73. PubMed ID: 8930738
[TBL] [Abstract][Full Text] [Related]
18. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].
Carbucicchio C; Lavarra F; Riva S; Fassini G; Della Bella P
Cardiologia; 1995 Dec; 40(12):927-40. PubMed ID: 8901043
[TBL] [Abstract][Full Text] [Related]
19. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
Greiser M; Neuberger HR; Harks E; El-Armouche A; Boknik P; de Haan S; Verheyen F; Verheule S; Schmitz W; Ravens U; Nattel S; Allessie MA; Dobrev D; Schotten U
J Mol Cell Cardiol; 2009 Mar; 46(3):385-94. PubMed ID: 19100271
[TBL] [Abstract][Full Text] [Related]
20. Atrioventricular conduction properties in patients with prolonged pauses undergoing ablation of longstanding persistent atrial fibrillation: do pauses during atrial fibrillation matter?
Sairaku A; Nakano Y; Oda N; Makita Y; Kajihara K; Tokuyama T; Motoda C; Fujiwara M; Kihara Y
J Interv Card Electrophysiol; 2012 Sep; 34(3):277-85. PubMed ID: 22354773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
